Cargando…

Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study

Remote control (RC) of cardiac implantable electronic devices (CIEDs) has been tested as safe and effective in the magnetic resonance imaging space. We sought to evaluate RC applications of patients at home. RC of cardiac devices in patients’ homes is feasible, safe, and effective, with consistent p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloosterman, Esteban Martin, Rosman, Jonathan Z., Berkowitz, Eric J., Rosenbaum, Murray, Wettenstein, Zachary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MediaSphere Medical 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983617/
https://www.ncbi.nlm.nih.gov/pubmed/36874562
http://dx.doi.org/10.19102/icrm.2023.14024
_version_ 1784900584237694976
author Kloosterman, Esteban Martin
Rosman, Jonathan Z.
Berkowitz, Eric J.
Rosenbaum, Murray
Wettenstein, Zachary
author_facet Kloosterman, Esteban Martin
Rosman, Jonathan Z.
Berkowitz, Eric J.
Rosenbaum, Murray
Wettenstein, Zachary
author_sort Kloosterman, Esteban Martin
collection PubMed
description Remote control (RC) of cardiac implantable electronic devices (CIEDs) has been tested as safe and effective in the magnetic resonance imaging space. We sought to evaluate RC applications of patients at home. RC of cardiac devices in patients’ homes is feasible, safe, and effective, with consistent patient satisfaction. Patients with CIEDs using the CareLink™ network (Medtronic, Minneapolis, MN, USA) participated in a pair of home RC sessions. A technician visited the patient’s house and set up a telehealth tablet and a programmer, which included inputting a session key enabling programmer access via a third-party host. The investigator video-conferenced with the patient and remotely controlled the programmer for device testing and data assessment, using a cellular hotspot for Internet connection. Reprogramming was performed as necessary. In all cases, an RC session legend was programmed in the device information field as a control. The patients then completed an experience questionnaire. One hundred fifty patients (99 pacemakers and 51 implantable cardioverter-defibrillators) completed 2 RC sessions, for 300 RC sessions in total. There were no complications or communication interruptions once the system communication proved stable after the first minute. In 26 sessions, initial communication was interrupted upon device interrogation, requiring communication to be re-established (which sometimes necessitated switching to an alternative carrier). Clinically driven parameter reprogramming was performed in 58 RC sessions (39%). Programming of notations concerning RC sessions was performed in all 300 sessions. The average duration of the RC sessions was 11 min. Patients’ satisfaction scored 4.5 out of 5 points. In conclusion, RC management of cardiac devices at patients’ homes is safe, effective, convenient, and associated with high patient satisfaction. This technology may prove very useful in a changing health care delivery system, especially amid the coronavirus disease 2019 pandemic.
format Online
Article
Text
id pubmed-9983617
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MediaSphere Medical
record_format MEDLINE/PubMed
spelling pubmed-99836172023-03-04 Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study Kloosterman, Esteban Martin Rosman, Jonathan Z. Berkowitz, Eric J. Rosenbaum, Murray Wettenstein, Zachary J Innov Card Rhythm Manag Original Research Remote control (RC) of cardiac implantable electronic devices (CIEDs) has been tested as safe and effective in the magnetic resonance imaging space. We sought to evaluate RC applications of patients at home. RC of cardiac devices in patients’ homes is feasible, safe, and effective, with consistent patient satisfaction. Patients with CIEDs using the CareLink™ network (Medtronic, Minneapolis, MN, USA) participated in a pair of home RC sessions. A technician visited the patient’s house and set up a telehealth tablet and a programmer, which included inputting a session key enabling programmer access via a third-party host. The investigator video-conferenced with the patient and remotely controlled the programmer for device testing and data assessment, using a cellular hotspot for Internet connection. Reprogramming was performed as necessary. In all cases, an RC session legend was programmed in the device information field as a control. The patients then completed an experience questionnaire. One hundred fifty patients (99 pacemakers and 51 implantable cardioverter-defibrillators) completed 2 RC sessions, for 300 RC sessions in total. There were no complications or communication interruptions once the system communication proved stable after the first minute. In 26 sessions, initial communication was interrupted upon device interrogation, requiring communication to be re-established (which sometimes necessitated switching to an alternative carrier). Clinically driven parameter reprogramming was performed in 58 RC sessions (39%). Programming of notations concerning RC sessions was performed in all 300 sessions. The average duration of the RC sessions was 11 min. Patients’ satisfaction scored 4.5 out of 5 points. In conclusion, RC management of cardiac devices at patients’ homes is safe, effective, convenient, and associated with high patient satisfaction. This technology may prove very useful in a changing health care delivery system, especially amid the coronavirus disease 2019 pandemic. MediaSphere Medical 2023-02-15 /pmc/articles/PMC9983617/ /pubmed/36874562 http://dx.doi.org/10.19102/icrm.2023.14024 Text en Copyright: © 2023 Innovations in Cardiac Rhythm Management https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Kloosterman, Esteban Martin
Rosman, Jonathan Z.
Berkowitz, Eric J.
Rosenbaum, Murray
Wettenstein, Zachary
Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title_full Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title_fullStr Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title_full_unstemmed Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title_short Remote-control Interrogation, Testing, and Reprogramming of Cardiac Implantable Electronic Devices with Telehealth Protocol for the Management of Patients at Home: The DOMUM REMOTUS Study
title_sort remote-control interrogation, testing, and reprogramming of cardiac implantable electronic devices with telehealth protocol for the management of patients at home: the domum remotus study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983617/
https://www.ncbi.nlm.nih.gov/pubmed/36874562
http://dx.doi.org/10.19102/icrm.2023.14024
work_keys_str_mv AT kloostermanestebanmartin remotecontrolinterrogationtestingandreprogrammingofcardiacimplantableelectronicdeviceswithtelehealthprotocolforthemanagementofpatientsathomethedomumremotusstudy
AT rosmanjonathanz remotecontrolinterrogationtestingandreprogrammingofcardiacimplantableelectronicdeviceswithtelehealthprotocolforthemanagementofpatientsathomethedomumremotusstudy
AT berkowitzericj remotecontrolinterrogationtestingandreprogrammingofcardiacimplantableelectronicdeviceswithtelehealthprotocolforthemanagementofpatientsathomethedomumremotusstudy
AT rosenbaummurray remotecontrolinterrogationtestingandreprogrammingofcardiacimplantableelectronicdeviceswithtelehealthprotocolforthemanagementofpatientsathomethedomumremotusstudy
AT wettensteinzachary remotecontrolinterrogationtestingandreprogrammingofcardiacimplantableelectronicdeviceswithtelehealthprotocolforthemanagementofpatientsathomethedomumremotusstudy